CVS Health Co. (NYSE:CVS) Shares Purchased by Tokio Marine Asset Management Co. Ltd.

Tokio Marine Asset Management Co. Ltd. raised its position in shares of CVS Health Co. (NYSE:CVS) by 3.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 27,728 shares of the pharmacy operator’s stock after buying an additional 943 shares during the period. Tokio Marine Asset Management Co. Ltd.’s holdings in CVS Health were worth $2,189,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Wynn Capital LLC acquired a new stake in shares of CVS Health during the fourth quarter worth about $1,358,000. Alaska Permanent Fund Corp boosted its position in CVS Health by 1.4% during the 4th quarter. Alaska Permanent Fund Corp now owns 32,949 shares of the pharmacy operator’s stock worth $2,602,000 after purchasing an additional 449 shares during the period. F M Investments LLC purchased a new position in CVS Health in the 4th quarter valued at about $215,000. South Dakota Investment Council boosted its position in CVS Health by 3.9% in the 4th quarter. South Dakota Investment Council now owns 235,726 shares of the pharmacy operator’s stock valued at $18,613,000 after buying an additional 8,933 shares during the last quarter. Finally, NewSquare Capital LLC raised its stake in shares of CVS Health by 3.3% in the 4th quarter. NewSquare Capital LLC now owns 101,367 shares of the pharmacy operator’s stock valued at $7,892,000 after purchasing an additional 3,199 shares in the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on CVS shares. StockNews.com cut CVS Health from a “buy” rating to a “hold” rating in a report on Thursday, February 15th. SVB Leerink assumed coverage on shares of CVS Health in a research note on Monday, February 26th. They set an “outperform” rating and a $88.00 target price for the company. Royal Bank of Canada reduced their price objective on shares of CVS Health from $86.00 to $84.00 and set an “outperform” rating for the company in a research note on Thursday, February 8th. Wells Fargo & Company cut their target price on shares of CVS Health from $83.00 to $76.00 and set an “equal weight” rating for the company in a research report on Monday, April 8th. Finally, Barclays assumed coverage on shares of CVS Health in a report on Wednesday, March 6th. They set an “equal weight” rating and a $78.00 price objective on the stock. Four research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat, CVS Health has an average rating of “Moderate Buy” and an average target price of $89.44.

Insider Activity

In other CVS Health news, EVP Prem S. Shah sold 29,473 shares of the business’s stock in a transaction on Friday, February 16th. The stock was sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the transaction, the executive vice president now owns 39,765 shares of the company’s stock, valued at $3,059,916.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.24% of the company’s stock.

CVS Health Stock Performance

Shares of NYSE:CVS traded down $0.74 during mid-day trading on Thursday, reaching $67.03. 4,457,154 shares of the company traded hands, compared to its average volume of 10,648,894. CVS Health Co. has a 52 week low of $64.41 and a 52 week high of $83.25. The company has a debt-to-equity ratio of 0.77, a current ratio of 0.86 and a quick ratio of 0.63. The firm has a market cap of $84.49 billion, a PE ratio of 10.39, a PEG ratio of 0.91 and a beta of 0.52. The company’s 50 day moving average price is $74.80 and its 200-day moving average price is $73.72.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share for the quarter, topping analysts’ consensus estimates of $2.01 by $0.11. CVS Health had a return on equity of 15.25% and a net margin of 2.33%. The business had revenue of $93.81 billion for the quarter, compared to analyst estimates of $90.58 billion. During the same quarter last year, the firm posted $1.99 earnings per share. The business’s revenue was up 11.9% compared to the same quarter last year. On average, equities analysts expect that CVS Health Co. will post 8.31 EPS for the current fiscal year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 1st. Investors of record on Monday, April 22nd will be given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 3.97%. The ex-dividend date of this dividend is Friday, April 19th. CVS Health’s dividend payout ratio is currently 41.18%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.